A retrospective analysis of a wet age-related macular degeneration (AMD) study found nearly half of patients treated with aflibercept could safely stop treatment after one year without further vision loss, versus 17% of patients receiving bevacizumab injections.
Specialising in vitreoretinal and macula disorders, ocular tumours and complex cataracts, Dr Riyaz Bhikoo has joined the Auckland Eye team.
Two different types of retinal deposits may contribute to early age-related macular degeneration (AMD), with one of them also being indicative of undetected heart disease, reported authors of a new US study.
Health New Zealand/Te Whatu Ora has stopped accepting tenders in its search for a partner to design and build a simplified and unified National Data Platform (NDP) to reduce costs and inefficiencies.
After more than three years of development and five years wading through regulatory paperwork, a new device to permanently remove ingrown eyelashes (trichiasis and districhiasis) is now available to buy in New Zealand and Australia.
Makayla Kahi (Ngāti Kauwhata), is the winner of the inaugural Vision Research Foundation summer studentship, mentored by Professor Helen Danesh-Meyer.
Swept-source OCT (SS-OCT) biometer Argos is now available in New Zealand and Australia, achieving higher acquisition rates compared with other optical biometers, even in mature cataract cases, according to manufacturer Alcon.
Researchers in France found a subconjunctival dexamethasone implant used instead of steroid eye drops was safe, well tolerated and prevented graft rejection among penetrating keratoplasty (PK)
Responding to members’ feedback, The Cornea and Contact Lens Society’s (CCLS) popular one-day conference, scheduled for Sunday 26 March, will be held in Auckland at the Holiday Inn Auckland Airport. Attendees at the hybrid event will be shuttled between the venue and the airport by the Yellow Bus, p
Dr Simon Dean, an ophthalmic surgeon with subspeciality training in oculoplastic, anterior segment and ocular oncology, has joined the team at Re:Vision.
A small Australian study comparing CooperVision’s MiSight myopia-controlling disposable contact lenses and the myopia-control effects of two investigational spatio-temporal optical phase (STOP) soft contact lens designs (nthalmic/Brighten Optix’s F2 and DT) found F2 outperformed MiSight in some aspe
A multicentre Australian study found high polygenic risk among Europeans was associated with more rapid structural and functional progression in early primary open-angle glaucoma (POAG), despite more
